Peter Achenbach

6.2k total citations
104 papers, 3.5k citations indexed

About

Peter Achenbach is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Peter Achenbach has authored 104 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Genetics, 84 papers in Endocrinology, Diabetes and Metabolism and 77 papers in Surgery. Recurrent topics in Peter Achenbach's work include Diabetes and associated disorders (97 papers), Diabetes Management and Research (79 papers) and Pancreatic function and diabetes (76 papers). Peter Achenbach is often cited by papers focused on Diabetes and associated disorders (97 papers), Diabetes Management and Research (79 papers) and Pancreatic function and diabetes (76 papers). Peter Achenbach collaborates with scholars based in Germany, United States and United Kingdom. Peter Achenbach's co-authors include Ezio Bonifacio, Anette‐G. Ziegler, Kerstin Koczwara, Heike E. Naserke, Anette‐Gabriele Ziegler, Christiane Winkler, Annette Knopff, Alistair J.K. Williams, Katharina Warncke and Polly J. Bingley and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Peter Achenbach

92 papers receiving 3.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Achenbach 2.9k 2.3k 2.3k 462 412 104 3.5k
Cristian Guja 697 0.2× 637 0.3× 1.2k 0.5× 291 0.6× 630 1.5× 86 2.2k
Camilla Virili 393 0.1× 536 0.2× 1.2k 0.5× 159 0.3× 384 0.9× 74 2.0k
José Barbosa 786 0.3× 608 0.3× 891 0.4× 369 0.8× 255 0.6× 57 2.2k
Yoichi Oikawa 531 0.2× 479 0.2× 482 0.2× 319 0.7× 186 0.5× 99 1.3k
Mark K. Wedel 334 0.1× 537 0.2× 269 0.1× 221 0.5× 434 1.1× 30 1.6k
F. Rosina 218 0.1× 666 0.3× 528 0.2× 190 0.4× 249 0.6× 111 3.4k
Benedetta Maria Bonora 337 0.1× 503 0.2× 1.2k 0.5× 329 0.7× 592 1.4× 52 2.0k
Thorsten Vowinkel 247 0.1× 688 0.3× 106 0.0× 284 0.6× 270 0.7× 35 1.6k
David A. Dreiling 175 0.1× 1.5k 0.6× 326 0.1× 46 0.1× 213 0.5× 134 2.3k
Sukanta Ray 121 0.0× 775 0.3× 177 0.1× 175 0.4× 499 1.2× 83 1.8k

Countries citing papers authored by Peter Achenbach

Since Specialization
Citations

This map shows the geographic impact of Peter Achenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Achenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Achenbach more than expected).

Fields of papers citing papers by Peter Achenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Achenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Achenbach. The network helps show where Peter Achenbach may publish in the future.

Co-authorship network of co-authors of Peter Achenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Achenbach. A scholar is included among the top collaborators of Peter Achenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Achenbach. Peter Achenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wolfes, Julian, Peter Achenbach, Felix K. Wegner, et al.. (2025). Cardiac Electrophysiological Effects of the Sodium Channel-Blocking Antiepileptic Drugs Lamotrigine and Lacosamide. Pharmaceuticals. 18(5). 726–726. 1 indexed citations
3.
Krischer, Jeffrey P., Sarah Müller, Peter Achenbach, et al.. (2025). Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays. Diabetes. 74(9). 1535–1546.
4.
Berge, Thekla von dem, et al.. (2025). Früherkennung des Typ-1-Diabetes im Kindesalter. Monatsschrift Kinderheilkunde.
5.
Mallone, Roberto, Emily K. Sims, Peter Achenbach, et al.. (2024). Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future. Diabetes. 74(1). 12–21. 3 indexed citations
6.
Shuck, Sarah C., Peter Achenbach, Bart O. Roep, et al.. (2023). Methylglyoxal products in pre-symptomatic type 1 diabetes. Frontiers in Endocrinology. 14. 1108910–1108910. 5 indexed citations
7.
Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2023). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Medicine. 21(1). 190–190. 13 indexed citations
8.
Puente-Marín, Sara, Fabrícia Dietrich, Peter Achenbach, et al.. (2023). Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype. Frontiers in Immunology. 14. 1112570–1112570. 7 indexed citations
9.
Ng, Kenney, Vibha Anand, Harry Stavropoulos, et al.. (2022). Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Diabetologia. 66(1). 93–104. 8 indexed citations
10.
Sola‐Gazagnes, A., Catherine Pecquet, Stefano Berrè, et al.. (2022). Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia. 65(8). 1278–1290. 8 indexed citations
11.
Kwon, Bum Chul, Peter Achenbach, Vibha Anand, et al.. (2022). Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes. Diabetes. 71(12). 2632–2641. 2 indexed citations
12.
Kwon, Bum Chul, Vibha Anand, Peter Achenbach, et al.. (2022). Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories. Nature Communications. 13(1). 1514–1514. 22 indexed citations
13.
Weiß, Andreas, Jose Zapardiel‐Gonzalo, Manja Jolink, et al.. (2022). Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening. Diabetologia. 65(12). 2121–2131. 31 indexed citations
14.
Winkler, Christiane, et al.. (2022). Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany. Diabetes Care. 45(4). 837–844. 22 indexed citations
15.
Ng, Kenney, Harry Stavropoulos, Vibha Anand, et al.. (2021). Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children. Diabetes Care. 45(1). 160–168. 9 indexed citations
16.
Ziegler, Anette‐Gabriele, Peter Achenbach, Reinhard Berner, et al.. (2021). Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol. BMJ Open. 11(11). e052449–e052449. 21 indexed citations
17.
18.
19.
Achenbach, Peter. (2018). Früherkennung und präventive Behandlung des Typ-1-Diabetes. Der Diabetologe. 14(4). 212–213. 1 indexed citations
20.
Achenbach, Peter, Kerstin Koczwara, Annette Knopff, et al.. (2004). Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. Journal of Clinical Investigation. 114(4). 589–597. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristian Guja Breakdown of academic impact, for papers by Camilla Virili Breakdown of academic impact, for papers by José Barbosa Breakdown of academic impact, for papers by Yoichi Oikawa Breakdown of academic impact, for papers by Mark K. Wedel Breakdown of academic impact, for papers by F. Rosina Breakdown of academic impact, for papers by Benedetta Maria Bonora Breakdown of academic impact, for papers by Thorsten Vowinkel Breakdown of academic impact, for papers by David A. Dreiling Breakdown of academic impact, for papers by Sukanta Ray
Rankless by CCL
2026